20:48 EDT Cathie Wood’s ARK Investment buys 294K shares of Crispr Therapeutics (CRSP) today
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Cathie Wood Doubles Down on Nvidia Stock (NVDA) Ahead of Q1 Earnings
- Cathie Wood’s ARK Investment buys 262K shares of Crispr Therapeutics today
- Crispr Therapeutics AG: Promising Partnership with Sirius Therapeutics Amidst Clinical and Market Uncertainties Warrants Hold Rating
- Crispr Therapeutics call volume above normal and directionally bullish
- Strategic Growth and De-risking: Gil Blum’s Buy Rating on Crispr Therapeutics AG